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Aims The adult mammalian heart has poor regenerative capacity. In contrast, the zebrafish heart retains a robust capacity for
regeneration into adulthood. These distinct responses are consequences of a differential utilization of evolutionary-
conserved gene regulatory networks in the damaged heart. To systematically identify miRNA-dependent networks
controlling cardiac repair following injury, we performed comparative gene and miRNA profiling of the cardiac tran-
scriptome in adult mice and zebrafish.
Methods
and results
Using an integrated approach, we show that 45 miRNA-dependent networks, involved in critical biological pathways,
are differentially modulated in the injured zebrafish vs. mouse hearts. We study, more particularly, the miR-26a-
dependent response. Therefore, miR-26a is down-regulated in the fish heart after injury, whereas its expression
remains constant in the mouse heart. Targets of miR-26a involve activators of the cell cycle and Ezh2, a component
of the polycomb repressive complex 2 (PRC2). Importantly, PRC2 exerts repressive functions on negative regulators
of the cell cycle. In cultured neonatal cardiomyocytes, inhibition of miR-26a stimulates, therefore, cardiomyocyte pro-
liferation. Accordingly, miR-26a knockdown prolongs the proliferative window of cardiomyocytes in the post-natal
mouse heart.
Conclusions This novel strategy identifies a series of miRNAs and associated pathways, in particular miR-26a, which represent at-
tractive therapeutic targets for inducing repair in the injured heart.
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1. Introduction
Heart failure, as a result of acute or progressive cardiomyocyte loss, is
a major cause of mortality in theWestern world.1 Recently, the notion
of promoting cardiac regeneration as a means to replace lost cardio-
myocytes has gained considerable research interest.2,3 Unlike the
mammalian heart, which has a poor regenerative capacity, certain fish
and amphibians retain a robust capacity for regeneration into adult life.
For example, zebrafish are able to fully regenerate their myocardium
after injuries such as ventricular resection, cryoinjury, or genetic abla-
tion of cardiomyocytes.4–6 Lineage tracing experiments have revealed
that de-differentiated cardiomyocytes are the primary source of newly
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formed myocytes in the regenerating fish heart. In response to injury,
pre-existing mature cardiomyocytes undergo a process of sarcomeric
disassembly, re-entry into the cell cycle and proliferation.7 –9 Finally,
cardiomyocytes proceed to maturation and functionally re-integrate
with the remaining nascent myocardium. Interestingly, progressive car-
diomyocyte replacement in the injured area occurs concomitantly with
local regression of fibrotic tissue formation. Neonatal mice also exhibit
a comparable regenerative capacity, although this capacity is strictly re-
stricted to the first week after birth; a period in which existing cardio-
myocytes have not terminally exited the cell cycle.10–12 Interestingly,
apical excision in these newborn mice results in cardiomyocyte prolif-
eration compared with that observed in zebrafish,10 suggestive of
evolutionary-conserved repair pathways. However, once cardiomyo-
cytes have completed terminal differentiation, the injured myocardium
undergoes the stereotypical maladaptive reparative response asso-
ciated with cardiomyocyte hypertrophy and fibrosis.13,14
Comparing biological pathways that are differentially modulated in
the regenerating zebrafish heart vs. the non-regenerating mammalian
heart might reveal biological mechanisms involved in regulating healing
processes. Moreover, repair circuits are enacted by the integrated exe-
cution of specific transcriptional programs, which are also modulated
by non-coding regulatory factors, including microRNAs (miRNAs).15,16
Recent studies have revealed central roles for miRNAs as core regula-
tors of gene expression during cardiac development and disease.17,18
Cardiac miRNAs appear to be particularly important for modulating
various cellular processes implicated in the maladaptive reparative re-
sponse such as inflammation, and hypertrophic and fibrotic path-
ways.19–22 In addition, miRNAs are important modulators of the cell
cycle in a number of different tissues, in particular in the heart.23,24
Along these lines, miRNAs have been implicated in the regenerative re-
sponses of the skeletal muscle and the heart in both mouse and zebra-
fish.24–27 Finally, several studies have also revealed a role for miRNAs
in controlling the epigenome early during development and the post-
natal life.28,29 Therefore, evolutionary-conserved miRNA-dependent
networks could be particularly important in regulating functional mod-
ules controlling repair processes.
To systematically identify miRNA-dependent regulatory circuits im-
plicated in adaptation and repair, we generated global gene and miRNA
expression profiles in the injured heart of the mouse and the zebrafish.
We developed an integrated bioinformatic approach to identify differ-
entially regulated miRNA-dependent programs in the two injury mod-
els. Several differentially modulated networks appeared to be
controlled by well-characterized miRNAs implicated in cardiac fibrosis
and hypertrophy. Additionally, this global miRome characterization
identified many novel miRNA-dependent networks involved in critical
biological pathways relevant to cardiac healing. In particular, we found
that miR-26a was down-regulated in the damaged fish heart, whereas
its expression remained unchanged in the mouse heart after infarction.
One important target of miR-26a is Ezh2, a component of the poly-
comb repressor complex 2 (PRC2), which has been shown to favour
myocyte proliferation and to control expression of the appropriate
gene program in differentiating cardiomyocytes during development
of the heart.30,31 Cardiomyocyte proliferation was indeed found to
be stimulated in the neonatal mouse heart following miR-26a inhibition
and Ezh2 re-expression.
2. Methods
See Supplementary material online for detailed Methods section.
2.1 Zebrafish and ventricular resection model
Zebrafish experiments were approved by the Government Veterinary Of-
fice and performed according to the guidelines from Directive 2010/63/EU
of the European Parliament. Wild-type AB fish strain was raised and kept
under standard laboratory conditions at 28.58C. For ventricular resection,
adult zebrafish at 12 months of age were anaesthetized in tricaine
(A-5040, Sigma). The chest was opened and 20% of the ventricle muscle
at the apexwas surgically removed. The regenerating tissues were collected
2 weeks after surgery. Ventricular muscle from sham-operated fish was
used as control.
2.2 Mice and myocardial infarction model
Mouse experiments were approved by the Government Veterinary Office
and performed according to the guidelines from Directive 2010/63/EU of
the European Parliament. Male C57BL/6J mice at 12 weeks of age were
obtained from Charles River, France. Myocardial infarction in mice was
induced by permanent ligation of the left anterior descending artery. Adult
micewere sacrificed by CO2 inhalation and subsequent cervical dislocation.
Neonatal mice were sacrificed by rapid decapitation.
2.3 Administration of LNA-modified
oligonucleotides
Locked nucleic acid (LNA) anti-miR-26a oligonugleotides were purchased
from Exiqon. Neonatal C57BL/6J mice were injected i.p. with 10 mg/kg
LNA at day 2 (d2), d4, and d6 of age.
2.4 Transfection of rat neonatal
cardiomyocytes
Ventricular cardiomyocytes were isolated from neonatal Sprague–Dawley
rats by enzymatic digestion and differential plating to remove non-myocyte
cells. Non-adherent neonatal myocytes were transfected with 50 nM LNA
anti-miR-26a or scrambled LNA.
2.5 Immunohistochemistry
Cardiomyocyte cultures and heart tissue sections were fixed in 4% paraf-
ormaldehyde (PFA) permeabilized with 0.25% Triton X-100, and processed
for immunostaining. The stained cultures and tissue sections were observed
using an Axiovision fluorescence microscope (Carl Zeiss) and images were
acquired at ×40 magnification using a CCD camera. Cardiomyocyte prolif-
eration was quantified by counting BrdU- or Aurora B-positive cardiomyo-
cytes on the acquired images. The cardiomyocyte size was determined by
measuring their cross-sectional area using the NIH ImageJ software. Con-
trol and resected zebrafish hearts were dissected, fixed at appropriate time
points in 4% PFA, and cryopreserved in 30% sucrose/phosphate-buffered
saline. Twelve micrometer-embedded frozen sections were stained with
haematoxylin and eosin for light microscopy histology examination.
2.6 Echocardiographic assessment of cardiac
dimensions and function
Transthoracic echocardiography was performed using a Vevo 2100 ultra-
sound machine and an 18–38 MHz probe (VisualSonics, Toronto, ON,
Canada).
2.7 Statistical analysis
All data are presented as mean+ standard error of the mean (SEM). Stat-
istical analysis was carried out using the Prism software (GraphPad). For
statistical comparison of two groups, unpaired, two-tailed Student’s t-test
was used; for multiple comparisons, one-way ANOVAwith Bonferroni cor-
rection was used. All the data meet the assumption of the statistical tests
used. A value of P, 0.05 was considered significant.
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3. Results
3.1 Global gene profiling of the injured
mouse and zebrafish hearts
To investigate the molecular mechanisms underlying cardiac repair, we
designed an integrative genomics and bioinformatics strategy to inter-
rogate miRNAs and their potential target genes to identify major path-
ways differentially utilized in the mouse and zebrafish hearts after injury
(see Supplementary material online, Figure S1A). We measured the ex-
pression of mature miRNAs and mRNA transcripts, on the one hand, in
the border zone of the infarcted mouse heart and, on the other hand, in
the regenerating tissue of the injured Zebrafish heart. Putative miRNA
targeting was predicted by combining miRNA–mRNA correlation with
seed-match enrichment analyses, which were combined into separate
orthologous miRNA networks for mouse and zebrafish. We explored
the predicted miRNA–target interactions and were able to identify a
set of miRNAs and predicted target genes that were differentially
modulated between the two species.
Therefore, myocardial infarction was induced in the mouse heart by
ligation of the left anterior descending artery. Fourteen days postinfarc-
tion, the heart was characterized by intense remodelling as well as com-
promised function (see Supplementary material online, Figures S1B).
RNA was then isolated from the border zone of the infarcted region
and from a corresponding zone in sham-operated animals. Analysis de-
monstrated the expected reactivation of the fetal gene program includ-
ing up-regulation of cardiac stress marker genes such as Nppa, Nppb,
Myh7, Col1a1, Postn, and Tgfb1, in addition to stereotypical myosin hea-
vy chain isoform switching (see Supplementary material online, Figures
S1C). In the zebrafish, 20% of the ventricular apex was surgically
removed. We then observed a robust regenerative response in the
resected heart, which led to a complete replenishment with new
myocardium by 30 days post amputation (see Supplementary material
online, Figure S1D). Regeneration-associated genes, including Cxcl12a,
Mdka, and Vegfc, were activated in the injured heart (see Supplemen-
tary material online, Figure S1D). RNA isolated from both species was
subjected to high-throughput transcriptomic profiling. In the mouse
heart, we identified 3398 up-regulated and 3193 down-regulated cod-
ing transcripts after infarction (see Supplementary material online, Fig-
ure S2A and Table S1). To gain insights into significantly modulated
biological pathways, gene set enrichment analysis (GSEA) was per-
formed. Pathways associated with fibrosis, apoptosis, and pathological
cardiac remodelling were significantly activated (see Supplementary
material online, Figures S2B and S3B and Table S2). We identified 563
up-regulated genes and 328 down-regulated genes in regenerating zeb-
rafish cardiac tissues (see Supplementary material online, Figure S2C and
Table S3). GSEA suggested that most differentially modulated genes be-
long to pathways involved in the control of proliferation (see Supple-
mentary material online, Figures S2D and S3C, and Table S2). A
comparative GSEA was performed on differentially modulated ortho-
logous genes between the mouse and the fish. Interestingly, pathways
implicated in fibrosis and cell cycle control appeared to be differently
utilized in the two species during the response of the heart to injury
(see Supplementary material online, Figure S3A and D, and Table S4).
MaturemiRNAs were identified using small RNA-Sequencing (RNA-
Seq). Analysis of individual libraries in bothmouse and fish revealed that
the vast majority of reads mapped to known miRNAs (see Supplemen-
tary material online, Figures S4A and E). A total of 271 mature miRNAs
were detected in the mouse; among these, 74 were up-regulated and
20 were down-regulated (see Supplementary material online, Figures
S4B and C, and Table S5). Unsupervised hierarchical clustering using
all expressed miRNAs identified two distinct clusters corresponding
to the sham and infarction libraries, suggesting that miRNAs are
co-ordinately responsive to cardiac injury (see Supplementary material
online, Figure S4D). In the zebrafish, of the 158 detected miRNAs, 23
were up-regulated and 25 were down-regulated in regenerating tissue
(see Supplementary material online, Figures S4F, G and Table S5). As for
the mouse, clustering analysis detected two distinct clusters corre-
sponding to the control and resection libraries, indicating that the zeb-
rafish miRome was sensitive to cardiac injury and supporting a role for
miRNAs in fine-tuning gene expression during cardiac regeneration
(see Supplementary material online, Figure S4H).
3.2 Identification of differentially utilized
miRNA-dependent networks
Given the regulatory power of miRNAs in stress-activated signalling
networks, we hypothesized that differentially utilized miRNAs during
the response to cardiac injury between the two species would likely re-
present important candidates for modulating adaptive pathways in-
volved in reparative healing. We therefore performed orthology
mapping to identify all orthologous miRNAs between mouse and zeb-
rafish, defined as demonstrating complete identity in the seed sequence
and more than 50% identity in the adjacent sequences. We detected
106 orthologous miRNAs (see Supplementary material online, Table
S6), of which 45 were differentially modulated between the two cardiac
injury models (Figure 1A, left panel). Encouragingly, many of these
miRNAs have been implicated in the response of the heart to stress.
Modulated miRNAs, target mRNAs, and miRNA–mRNA correlation
were then visualized as nodes and edges in regulatory networks. The
mouse network contained 646 nodes and 5225 edges, and the zebra-
fish network contained 536 nodes and 2293 edges (see Supplementary
material online, Figure S1A). To gain a more global view of the mouse
and zebrafish networks, we integrated the pathway analysis data into
each network and visualized the two species-specific networks as hive-
plots (Figure 1B–D). Each axis represents an miRNA (black axis), a pre-
dicted target gene (cyan axis), or a pathway (magenta axis). In Figure 1B
and C, the arcs connecting the axes represent positive (red) and nega-
tive (blue) correlation between nodes. Grey arcs indicate targeting of
inferred miRNA-dependent pathways. It is apparent from the species-
specific plots that the mouse and zebrafish networks are different,
reflecting a different response to cardiac injury. Figure 1D shows a re-
presentation of the combined mouse vs. zebrafish network, where
the edges unique to each model are coloured differently (purple for
edges unique to the mouse, green for edges unique to the zebrafish,
and red for edges common to mouse and zebrafish). An interesting ob-
servation that these figures suggest is that, even though miRNAs in
both mouse and zebrafish are positively and negatively correlated
with the predicted target genes, the net effect in both organisms ap-
pears to be up-regulation, not down-regulation, of pathways related
to these target genes. This can be seen by the red lines (positive regu-
lation) linking the genes with the pathways (Figure 1B and C ).
To maximize the chance of identifying relevant subnetworks, we
focused on 14 orthologous miRNAs having a D-fold change greater
or smaller than 2 between the two injury models (Figure 1A, right pa-
nel). Several of these modulated miRNAs have no known roles in
the heart. However, predicted target genes appeared to be implicated
in cellular processes important to potential regenerative responses.
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Indeed, novel cardiac miRNAs have been implicated in cell cycle con-
trol (miR-31,32 -26a,33–36 -182,37,38 -183,39 -184,40 -193b41), in cellular
migration (miR-31,42 -182,43 -18344), in vasculogenesis (miR-3145), and
in inflammatory and fibrotic responses (miR-18146,47). For instance,
miR-193b was down-regulated in the zebrafish heart. Since miR193b
is a potent modulator of cellular proliferation and migration, partly
through its ability to target cyclin D1,41 therapeutic down-regulation
of miR-193b in the mouse heart could support a regenerative response
via induction of cell cycle re-entry. Interestingly, three miRNAs, previ-
ously shown to be important modulators of pathological remodelling in
the mouse heart, namely miR-133a, -30c, and -499,20,48–50 interact to
form a single subnetwork (Figure 2A). These three miRNAs were signifi-
cantly down-regulated in the damaged mouse heart, whereas their ex-
pression was higher in the regenerating fish heart. Three genes
appeared to be targeted by all three miRNAs and modulated in an
anti-correlated manner (Figure 2A; see Supplementary material online,
Tables S1 and S3). Gli2, a transcription factor and important component
of the hedgehog signalling pathway, Fbln5, an integrin-binding matricel-
lular protein that has been shown to be reactivated in injured tissues,
and Lhfpl2, a gene of unknown function with little coding potential,
were indeed predicted to represent prime targets of miRNA-133a,
-30c, and -499. Fbln5 and Gli2 are particularly interesting because
both have been implicated in modulating processes that may be in-
volved in cardiac repair.51–53 Gli2 has been shown to interact with an
important cardiac transcription factor, myocyte enhancer factor 2C
(Mef2c), forming a gene regulatory circuit capable of activating cardiac-
specific programs associated with pathological cardiac hypertrophy.
Fbln5 is an integrin-binging matricellular protein that modulates cellular
functions implicated in the response of injured tissues. Quantitative
analysis confirmed the modulation of the respective miRNAs and
Figure 1 miRNAs and pathways are differentially utilized in the injured mouse and zebrafish hearts. (A) Differentially utilized subnetworks in the
mouse and zebrafish hearts following injury were extracted for further analysis. List of the 45 orthologous miRNAs differentially modulated between
the two cardiac injury models. The bar graph represents the fold change in the expression level of the indicatedmiRNAs in the infarctedmouse heart (red
bars) and in the resected zebrafish hearts (green bars), relative to their respective controls (Sham mouse hearts and control zebrafish hearts), in which
the expression level is set as 1 (dashed vertical black line). A selection of 14 orthologous miRNAs having a D-fold change between the two cardiac injury
models greater or smaller than 2 is shown on the right. (B–D) Hive plot representation of differentially expressed miRNAs (black axes), predicted target
genes (magenta axes), and pathways (cyan axes) in the injured mouse and zebrafish hearts. (B) Red lines (arcs) indicate positive correlation; blue lines
indicate negative correlation. Grey lines indicate targeting of inferred miRNA-dependent pathways. (C ) Hive plot representation of differentially ex-
pressed miRNAs, mRNAs, and pathways in the resected zebrafish heart. Red lines indicate positive correlation; blue lines indicate negative correlation.
Grey lines indicate targeting of inferred miRNA-dependent pathways. (D) Hive plot representation of miRNA, mRNA, and pathway relationships unique
to the mouse (purple) or to the zebrafish (green). Red lines indicate relationships common to mouse and zebrafish. See also Supplementary material
online, Figure S1–S4 and Table S1–S6.
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Figure 2 miR-30c-, miR-133a-, and miR-499-dependent subnetwork. (A) Subnetwork around miR-30c, miR-133a, and miR-499. Node colours re-
present changes in expression between the two injury models: red lines indicate greater up-regulation or lesser down-regulation in the injured zebrafish
heart as compared with the injured mouse heart; blue indicates greater down-regulation or lesser up-regulation in the injured zebrafish heart as com-
pared with the injured mouse heart. Node colour in target genes is proportional to the log fold change. Edge colours represent positive (red) and nega-
tive (blue) correlation. Three genes, Fbln5, Lhfpl2, and Gli2, are potential targets for all three miRNAs; (B) miR-30c, miR-133a, and miR-499 expression
(left panel), and of Gli2 and Fbln5 expression (right panel) in control and resected zebrafish hearts. Data are expressed as mean+ SEM; n ≥ 4 for each
group; *P, 0.05, **P, 0.01. (C ) miR-30c, miR-133a, and miR-499 expression (left panel), and of Gli2 and Fbln5 expression (right panel) in
sham-operated and infarcted mouse hearts. Data are expressed as mean+ SEM; n ≥ 6 for each group; *P, 0.05, **P, 0.01. (D) Luciferase activity
measured in COS-7 cells 48 h after transfection with a luciferase reporter containing the Gli2 3′ UTR together with plasmids expressing either
miR-133a, miR-30c, or miR-499. Gli2*UTR indicates a reporter containing a mutated form of Gli2 3′ UTR. (E) Luciferase activity measured in
COS-7 cells 48 h after transfection with a luciferase reporter containing the Fbln5 3′ UTR together with plasmids expressing either miR-133a,
miR-30c, or miR-499. Fbln 5*UTR indicates a reporter containing a mutated form of Fbln5 3′ UTR. pN3-miRdsRED2x-WPRE-eGFP was used as miRNA
control. Data are expressed as mean+ SEM. Experiments were performed in triplicates; n ≥ 3; *P, 0.05, **P, 0.01. See also Supplementary material
online, Table S1, S3, and S7.
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target mRNAs in both zebrafish and mouse injury models (Figure 2B
and C ). We also conducted 3′RTR luciferase reporter assays to deter-
mine whether miR-133a, -30c, and -499 could directly target Fbln5 and
Gli2 for repression. As expected, the expression of the Gli2- and Fbl5
3′UTR-containing reporters was repressed by each one of the three
miRNAs (Figure 2D and E). Repression of luciferase activity was partially
relieved by mutations affecting the binding sites for miR-133a, -30c, and
-499. Altogether, these data validated the integrated network approach
described above to predict bona fide miRNA targets and miRNA-
dependent subnetworks.
3.3 The miR-26a-dependent network
To select key miRNAs for further study, we decided to focus on
miRNAs that were down-regulated in zebrafish compared with mouse.
We reasoned that such miRNAs should control key processes, de-
repression of which could favour repair in the damaged mouse heart.
Additionally, such miRNAs are amenable to antagomir therapy in the
mammalian heart, and therefore be useful targets in a clinical setting.
Since we were searching for key miRNAs controlling differential
reparative healing in zebrafish and mouse, we chose also to focus on
the most highly expressed miRNAs in the two models. We therefore
employed a strategy to rank differentially expressed zebrafish miRNAs
according to the following criteria: (i) log 2-fold change (resected vs.
control); (ii) FDR for differential expression; (iii) mean normalized
expression in zebrafish; and (iv) mean normalized expression in mouse.
We then calculated an overall priority from the individual ranks, and
ordered the miRNAs. The result indicated miR-26a as the top ranking
miRNA according to the above criteria (see Supplementary material
online, Table S7). We therefore focused on this miRNA as a key
candidate for involvement in the differential response observed
between mouse and zebrafish models.
RNASeq analysis showed miR-26a to be the most highly expressed
of all detectedmiRNAs in the zebrafish heart, representing around 10%
of the total read counts in control samples. The miRNA belongs to a
family containing four members in zebrafish and five in mouse (see Sup-
plementary material online, Figure S5A). Thus, miR-26a was strongly
down-regulated in the regenerating zebrafish heart, but remained un-
changed in the mouse infarcted heart (Figure 3A). The expression of
miR-26b, which was 3–5 times lower than the expression of
miR-26a in both species, did not change the following injury (see Sup-
plementary material online, Figure S5B). Interestingly, miR-26a is em-
bedded into intronic sequences of the Ctdspl genes (Ctdspla and
Ctdsplb) encoding a phosphatase, which regulates the cell cycle via
Rb dephosphorylation.33 Ctdspl genes and miR-26a were co-regulated
in the injured fish and mouse hearts, suggesting that they might be tran-
scribed from the same promoter (see Supplementary material online,
Figure S5C). As expected, predicted miR-26a targets such as Mdka, Plo-
d1A, Angptl2, and Ndrg1 were more expressed in the zebrafish heart
after injury compared with the infarcted mouse heart (Figure 3B). Net-
work analysis also identified target genes that were previously impli-
cated in biological processes relevant to cardiac repair such as
angiogenesis and matrix reorganization (not shown).54–59 Interestingly,
miR-26a was recently shown in cancer cells to target the cell cycle in-
ducers Ccne1, Ccne2, Ccnd2, and Cdk6 (see Supplementary material on-
line, Figure S5D).33,60 Consistent with the observed modulation of
miR-26a after injury, expression of Ccne1, Ccne2, Ccnd2, and Cdk6
was activated in the regenerating fish hearts, but not in the infarcted
mouse heart (Figure 3C). Furthermore, miR-26a also targets Ezh2
(see Supplementary material online, Figure S5D), a component of the
polycomb repressor complex (PRC)2, which has been implicated in
the mouse heart in cardiomyocyte proliferation during development
and in the maintenance of cardiac identity.30,31,61 In particular, Ezh2 ab-
lation de-represses expression of several negative regulators of the cell
cycle such as Cdkn1a, Cdkn2a, and Cdkn2b, and many fetal and non-
cardiac genes such as Nppa, Nppb, Myh7, Tgfb1, Tgfb3, Postn, and
Spp1. Ezh2 expression was dramatically induced in the resected zebra-
fish heart concomitantly with miR-26a down-regulation, but unchanged
in the mouse heart (Figure 3D). Expression of Ezh1, an Ezh2 homologue
and component of PRC1, was not modulated in the two species.
3.4 miR-26a negatively regulates neonatal
cardiomyocyte proliferation
Considering the putative role of miR-26a in the control of the cell cycle,
we first evaluated the importance of miR-26a in neonatal cardiomyo-
cytes in vitro. It is noteworthy that miR-26a was found to be highly en-
riched in isolated mouse cardiomyocytes vs. non-myocyte cells
(Figures 4A). Therefore, we measured miR-26a levels in cultured cardi-
omyocytes, and observed a significant time-dependent induction of its
expression (Figure 4B). Isolated cardiomyocytes were then transfected
with LNA-modified oligonucleotides directed against miR-26a (LNA
miR26a) (see Supplementary material online, Figure S5E). Control cul-
tures received scrambled LNA oligonucleotides (LNA scr). Efficient in-
hibition of miR-26a expression was observed in LNA miR26a-treated
cardiomyocytes (Figure 4B). In turn, expression of miR-26a targets
such as Ccne1, Cdk6, and Ezh2 was up-regulated (Figure 4C and D). Im-
portantly, PRC2 is known to repress expression of negative regulators
of the cell cycle such as Cdkn1a (p21), Cdkn2a (p16), and Cdkn2b (p15)
in the developing heart.30,31 Indeed, Ezh2 target genes, i.e. Cdkn1a,
Cdkn2a, and Cdkn2b, were significantly repressed in LNA miR26a-
treated cardiomyocytes, which are characterized by high Ezh2 expres-
sion (Figure 4E). Altogether, this indicated that miR-26a played a critical
role in neonatal cardiomyocytes through direct and indirect (via Ezh2)
targeting of key cell cycle regulators. Therefore, to test whether
miR-26a inhibition increased proliferation of cardiomyocytes in vitro,
we quantified BrdU- and phosphohistone 3 (PH3)-positive cells in
transfected cultures after immunostaining (Figure 4F and G). The results
show that miR-26a inhibition significantly increased the percentage of
BrdU- and PH3-positive cardiomyocytes relative to scrambled LNA
transfected-cultures. Interestingly, PH3-positive cardiac myocytes de-
monstrated a diffuse a-actinin staining, suggesting that sarcomere disas-
sembly, a prerequisite for cardiomyocyte cytokinesis,62 was initiated in
treated cells (Figure 4F, inset). Cell count analysis showed that the num-
ber of cardiomyocytes was increased in the LNA miR26a transfected-
cultures relative to scrambled LNA (Figure 4H). Assessment of the cell
cycle in LNA miR26a-treated cardiomyocytes using propodium iodide
incorporation confirmed the accumulation of cells in the S and possibly
G2 phases (Figure 4I).
In the mammalian heart, cardiomyocytes stop proliferating early
after birth.11 We therefore analysed the expression of miR-26a in car-
diac ventricles during the perinatal period and in adulthood. The ex-
pression of miR-26a was dramatically induced at the end of the first
week of age, which coincides with the onset of cardiomyocyte terminal
differentiation (Figure 5A). As expected, the expression of Ccne1, Cdk6,
and Ezh2 was inversely correlated with miR-26a expression (Figure 5B).
To further investigate the role of miR-26a in suppressing cardiomyo-
cyte proliferation, neonatal mice were injected with LNA miR26a.
The anti-miR-26a oligonucleotides were administered during the first
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week of age, and cardiomyocyte production was assessed at Day 10
following BrdU injection (Figure 5C). The expression of miR-26a was
massively down-regulated in LNA miR26a-treated hearts, whereas
Ezh2 was markedly induced in response to miR-26a knockdown
(Figure 5D and E). Expression of the miR-26a target genes Ccne1,
Ccne2, Ccnd2, and Cdk6 at 10 days of age was not affected by
miR-26a inhibition (Figure 4E). In contrast, expression of the cell cycle
inhibitors Cdkn1a and Cdkn2a was significantly repressed as a result of
Ezh2 induction (Figure 5F). Importantly, inhibition of miR-26a increased
the number of BrdU-positive and Aurora B-positive cardiomyocytes
(Figure 5G and H ), suggesting that miR-26a inhibition, when cardiomyo-
cytes were permissive to cytokinesis, significantly stimulated cell div-
ision. Altogether, these data indicated that inhibition of Ezh2
expression by miR-26a regulated PRC2-mediated repression of nega-
tive cell cycle regulators, and then controlled cardiomyocyte prolifer-
ation in the neonatal heart.
4. Discussion
In the injured zebrafish heart, healing processes do not produce a fi-
brotic scar. Eventually, newly formed cardiomyocytes replenish the
lost myocardium. In parallel, studies in the mouse support the notion
that a latent regenerative capacity could be activated upon stimulation
of the appropriate pathways.2,3 The mammalian regenerative capacity
has been thought to rely in part on the reactivation of endogenous car-
diac stem cells, which could be then recruited to the site of injury. Re-
cent work suggests, however, that cardiomyocytes can also re-enter
the cell cycle in certain permissive situations.63,64 Along these lines,
miRNAs, identified for their capacity to promote neonatal cardiomyo-
cyte proliferation in vitro, have been recently proved to have the poten-
tial to restore cardiac function in adult mice after myocardial
infarction.24 Transcriptome-wide screenings have also identified sev-
eral miRNAs that are modulated during regeneration of the zebrafish
Figure 3 Expression analysis of miR-26a and target genes in the injured heart of the zebrafish and mouse. (A) miR-26a expression in injured zebrafish
(left panel) and mouse (right panel) hearts. (B) Expression of Mdka, Plod1a, Angptl2, and Ndrg1 in injured zebrafish (left panel) and mouse (right panel)
hearts. (C ) Expression of Ccne1, Ccne2, Ccnd2, and Cdk6 in injured zebrafish (left panel) and mouse (right panel) hearts. (D) Expression of Ezh2 and Ezh1
in injured zebrafish (left panel) and mouse (right panel) hearts. White bars: control fish heart and sham-operated mouse heart. Black bars: resected fish
heart and mouse infarcted heart. Data are expressed as mean+ SEM; n ≥ 4; *P, 0.05, **P, 0.01. See also Supplementary material online, Figure S5 and
Table S7.
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Figure 4 miR-26a controls proliferation in neonatal cardiomyocytes. (A) Expression of miR-26a in neonatal and adult cardiac myocytes (black bars)
and non-myocyte cells (white bars); data are expressed as mean+ SEM; **P, 0.01, n ¼ 5. (B) Time course analysis of miR-26a expression in neonatal
cardiomyocytes transfected with scrambled LNA (LNA scr; white bars) or anti-miR-26a LNA inhibitor (LNA miR26a; black bars). (C ) Expression of
Ccne1, Cdk6, and Ezh2 in neonatal cardiomyocytes transfected with LNA scr (white bars) or LNA miR26a (black bars). (D) Western blot analysis of
Ezh2 and Ccne1 expression in neonatal cardiomyocytes transfected with LNA scr or LNA miR26a. (E) Expression of Cdkn1a, Cdkn2a, and Cdkn2b in
neonatal cardiomyocytes transfected with LNA scr (white bars) or LNA miR26a (black bars). Data are expressed as mean+ SEM; n ≥ 3; *P, 0.05;
**P, 0.01. (F) In upper panels, immunostaining of BrdU-positive cells (red) transfected with LNA miR26a or with scrambled LNA; cardiomyocytes
are identified by a-actinin staining (green) and nuclei with DAPI (blue). In the lower panels, the bar graphs represent the percentage of total BrdU-
positive cells (left), the percentage of cardiomyocytes (middle) and the percentage non-myocytes (right) that are BrdU-positive. Data are mean+ SEM
of 56 fields per group; *P, 0.05, **P, 0.01. Scale bar: 50 mm. (G) In upper panels, immunostaining of phosphohistone 3 (PH3)-positive cells (red)
transfected with LNA miR26a or scrambled LNA scr (upper panel) or LNA miR26a (lower panel); cardiomyocytes are identified by a-actinin staining
(green) and nuclei with Hoechst (blue). In lower panels, bar graphs show the percentage of PH3-positive total cells (left), the percentage of cardiomyo-
cytes (middle) and of non-myocytes (right). Data are expressed as mean+ SEM of per cent PH3-positive cardiomyocytes in a minimum of 25 micro-
graphs taken at ×40 magnification per group; *P, 0.05, **P, 0.01. Scale bar: 50 mm. (H ) Cardiomyocyte cultures were transfected with either LNA
miR26a or with scrambled LNA and stained with a-actinin antibody. The bar graph shows average number+ SEM of cardiomyocytes per ×20 field in
triplicate cultures (56 fields each); **P, 0.01. (I ) Analysis of the cell cycle in neonatal cardiomyocytes following propidium iodide staining and cytometry
6 days after transfection with LNA scr (white bars) or LNA miR26a (black bars). An example of S-phase analysis is depicted in the left panel. Data are
expressed as mean+ SEM; n ≥ 3; *P, 0.05; **P, 0.01. See also Supplementary material online, Figure S5.
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heart and regulate cardiomyocyte dedifferentiation or prolifer-
ation.65,66 In the present study, we used a novel strategy to identify
miRNAs that could be used to promote repair in the injured adult
heart. By comparing the response with damage in the zebrafish and
the mouse, we aimed at identifying orthologous gene networks that
control the reparative response of the heart to injury. Since miRNAs
are a highly conserved class of small non-coding RNAs regulating
multiple target gene expression, they represent prime candidates for
coordinating global molecular responses. This approach represents,
therefore, the first of its kind to execute an integrated comparative
Figure 5 miR-26a regulates cardiomyocyte proliferation in the neonatal heart. (A) Time course of miR-26a expression in the postnatal mouse heart.
(B) Expression of the miR-26a target genes, Ccne1, Cdk6, and Ezh2, in the mouse heart at d1, d10, and d28 of age. (C) Schematic representation of the
protocol used to inhibit miR-26a in the neonatal mouse heart. (D) miR-26a expression in LNA scr (white bars) and LNA miR26a (black bars) treated
hearts at 10 days of age. (E) Expression of miR-26a target genes in LNA scr (white bars) and LNA miR26a (black bars) treated hearts. (F) Expression of
Ezh2 target genes, Cdkn1a, Cdkn2a, and Cdkn2b, in LNA scr (white bars) and LNA miR26a (black bars) treated hearts. Data are expressed as mean+
SEM; n ≥ 4; *P, 0.05, **P, 0.01. (G) Immunostaining of heart sections using anti-BrdU (red) anti-a-actinin (green) and anti-laminin (gray) antibodies
(upper panel), or using anti-Aurora B (red) and anti-a-actinin (green) antibodies (lower panel). Nuclei were stained with DAPI (blue). Scale bar: 20 mm in
upper panels and 10 mm in lower panels. (H ) Quantification of BrdU-positive cardiomyocytes, and Aurora B-positive cardiomyocytes per ×40 magni-
fication field in hearts of LNA scr (white bars) and LNA miR26a-treated (black bars) neonatal mice. Data are expressed as mean+ SEM; number of
analysed cardiac sections for each group ≥30; **P, 0.01.
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transcriptomic screen to identify orthologous miRNA-dependent
networks differentially modulated between two different species.
In keeping with the modulatory roles of cardiac miRNAs during the
responses to stress, our analysis demonstrates indeed the cardiac
miRome to be exquisitely sensitive to cardiac injury in both the mouse
and the zebrafish hearts.
To gain a deeper insight into miRNA-dependent networks, we de-
veloped a novel bioinformatic analysis, integrating mRNA and miRNA
expression profiles. More precisely, using a network approach across
two species and injury models allowed us to gain insights into key
cardiac stress miRNAs. Remarkably, 50% of orthologous cardiac
miRNAs were differentially modulated between the two species.
This strongly supports the existence of functional modules, each one
being under the control of one or several miRNAs, which determine
the balance between the pathological and regenerative responses.
Many of the differentially regulated miRNAs are indeed predicted to
interact with the same target genes, suggesting that multiple miRNAs
may co-ordinately regulate the stress response. For instance, three
miRNAs, miR-133a, miR-30c, and miR-499, formed a single sub-
network, in which they shared multiple differentially modulated
orthologous target genes. This reinforces each other’s regulatory po-
tency and potentially enacts unforeseen roles in the cardiac response
to stress. All three miRNAs have been previously characterized as
master modulators of maladaptive pathological responses in the
mouse.20,48–50 Thus, miR-133a controls cardiac hypertrophy, cardiac
fibrosis, cardiac apoptosis, and the cardiomyocyte cell cycle.20,25 Fur-
thermore, miR-30c modulates cardiac fibrosis synergistically with
miR-133a,48 targeting Ctgf, which was indeed identified as a predicted
target of both miR-133a and miR-30c. The model also reveals the po-
tential involvement of miR-499 in this sub-network. This miRNA is
highly expressed in cardiomyocytes and has previously been shown
to blunt the cardiac stress response through its modulation of the im-
mediate early gene program.49 We demonstrated that Gli2 and Fbln5
represent bona fide targets of all three miRNAs. Gli2 is an effector pro-
tein of sonic hedgehog signalling and has recently been demonstrated
to act synergistically with MEF2C to modulate cardiac gene regulatory
networks during cardiogenesis.51 Down-regulating a differentiation
program in cardiomyocytes via miRNA-dependent targeting of Gli2,
as observed in the zebrafish heart following injury, might be necessary
to promote de-differentiation of cardiomyocytes and facilitate cardio-
myocyte re-entry in the cell cycle.7,8,62 Then, Fbln5 represents an im-
portant matricellular protein implicated in extracellular matrix
stabilization,52 and is also a negative regulator of the normal angiogenic
process in vivo.53 Of note, the balance between a fibrotic vs. a regenera-
tive repair process is of crucial importance with respect to cardiac
adaptation to damage.67–69 Although production of extracellular ma-
trix proteins is crucial during regeneration in the zebrafish heart for
providing proliferating cardiomyocytes with a scaffold, one of the major
differences between the two species is the ultimate development of a
permanent fibrotic scar in the mammalian heart following injury and its
absence in the fish.70
We next demonstrate the importance of miR-26a in the control of
cell cycle of neonatal cardiomyocytes. Recently published data support
a role of miR-26a in non-myocyte cells, in particular endothelial cells
and fibroblasts, to control angiogenesis and fibrotic tissue depos-
ition.71,72 Here, we found that the level of miR-26a expression in non-
myocyte cells, either in the neonatal or the adult heart, is much lower
than that in cardiomyocytes. This indicates that modulation of miR-26a
expression exerts its effects on the heart largely via the myocyte
population. In the zebrafish heart, miR-26a is down-regulated during
the cardiomyocyte proliferative response to injury. mir-26a targets
key activators of the cell cycle in this species. We confirm that it is
also the case in mouse heart. Moreover, we demonstrated that Ezh2
is also a target of miR-26a and it is significantly up-regulated upon
miR-26a inhibition. Importantly, Ezh2 has been involved in the regula-
tion of myocyte proliferation during the formation of the compact
myocardium in the developing heart.30,31,61 Down-regulation of
miR-26a is expected therefore to promote cell cycle progression. In-
deed, inhibition of miR-26a in neonatal cardiomyocytes in vitro in-
creases proliferation and sustains cardiomyocyte expansion in vivo
during the neonatal period. Interestingly, proliferating myocytes in vitro
were characterized by the absence of organized sarcomeres, in accord-
ance with previous findings demonstrating that sarcomere disassembly
was a prerequisite for cardiomyocyte division.62 These results should
be placed into perspective with the observed down-regulation of
miR-26a in the zebrafish heart following injury, a species in which re-
generation relies on cardiomyocyte division.7,8 Therefore, miR-26a in-
hibition appears to induce proliferation of existing cardiomyocytes in
the neonatal heart, a developmental stage in which efficient regener-
ation occurs in the mammalian heart.10
Our integrative and comparative strategy identified relevant miRNA
networks in divergent species and injury models. One of the major
challenges is to elucidate tissue-specific and context-specific miRNA
functions. Many of the currently available tools provide useful insights
into putative miRNA targets. However, they do not take into account
the context and temporal nature of miRNA–target interactions. In
contrast, our species-, temporal- and context-specific integrative com-
parison of miRNA–mRNA networks provides an extremely powerful
means for identifying bona fide specific mRNA targets. Our data dem-
onstrate that evolutionary-conserved miRNA-dependent networks
are key regulatory determinants of both pathological responses and re-
pair in the adult heart. Through their concerted actions on cell cycle
regulatory genes and cardiac stress genes, miR-26a and its target
Ezh2 are identified as important players in the control of repair me-
chanisms in the heart (see Supplementary material online, Figure S6).
Therefore, miRNAs and their associated pathways may represent
attractive therapeutic targets for the treatment of heart failure via
maintenance of cardiac integrity within the mammalian myocardium.
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